目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.2. Product
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing demand for novel drug delivery devices
3.2.1.2. Increasing prevalence of chronic diseases
3.2.1.3. Technological advancement in drug delivery devices
3.2.1.4. Growing strategic alliances for drug delivery devices
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges associated with various routes of drug delivery devices
3.3. Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Drug Delivery Devices Market: Product Movement Analysis
4.3. Drug Delivery Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Inhalers
4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.1.1. Metered-dose inhalers (MDIs)
4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.1.2. Dry powder inhalers (DPIs)
4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.1.3. Others
4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Injection Devices
4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.1. Prefilled Syringes
4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.2. Auto-injectors
4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.3. Pen Injectors
4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.4. Needle-free Injectors
4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.1.5. Wearable Injectors
4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Implants
4.7.1. Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.1.1. Contraceptive Implants
4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.1.2. Drug-eluting Stents
4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.1.3. Biodegradable Implants
4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Topical Delivery System
4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.1. Creams
4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.2. Gels
4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.1.3. Ointments
4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Oral Delivery System
4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9.1.1. Controlled-release Tablets and Capsules
4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9.1.2. Buccal and Sublingual Tablets
4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Occular Delivery System
4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.11. Nebulizers
4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.12. Transdermal Patches
4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.13. Infusion Pumps
4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Drug Delivery Devices Market: Application Movement Analysis
5.3. Drug Delivery Devices Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Respiratory Diseases
5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Diabetes
5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Cardiovascular Diseases
5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Autoimmune Diseases
5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.11. Central Nervous System Disorders
5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Drug Delivery Devices Market: End-use Movement Analysis
6.3. Drug Delivery Devices Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Diagnostic Centers
6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Ambulatory Surgery Centers/Clinics
6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Home Care Settings
6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Others
6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Drug Delivery Devices Market Movement Analysis
7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.5. North America
7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Europe
7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. W. L. Gore & Associates, Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Abbott
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Terumo Medical Corporation
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Stryker
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Boston Scientific Corporation
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Novartis AG
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Becton, Dickinson and Company
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Teleflex Incorporated
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America drug delivery devices market, by country, 2021 - 2033 (USD Billion)
Table 4 North America drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 5 North America drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 6 North America drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 7 US drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 8 US drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 9 US drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 10 Canada drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 11 Canada drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 12 Canada drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 13 Mexico drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 14 Mexico drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 15 Mexico drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 16 Europe drug delivery devices market, by region, 2021 - 2033 (USD Billion)
Table 17 Europe drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 18 Europe drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 19 Europe drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 20 Germany drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 21 Germany drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 22 Germany drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 23 UK drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 24 UK drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 25 UK drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 26 France drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 27 France drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 28 France drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 29 Italy drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 30 Italy drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 31 Italy drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 32 Spain drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 33 Spain drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 34 Spain drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 35 Denmark drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 36 Denmark drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 37 Denmark drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 38 Sweden drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 39 Sweden drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 40 Sweden drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 41 Norway drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 42 Norway drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 43 Norway drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 44 APAC drug delivery devices market, by region, 2021 - 2033 (USD Billion)
Table 45 APAC drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 46 APAC drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 47 APAC drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 48 China drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 49 China drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 50 China drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 51 Japan drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 52 Japan drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 53 Japan drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 54 India drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 55 India drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 56 India drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 57 Thailand drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 58 Thailand drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 59 Thailand drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 60 South Korea drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 61 South Korea drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 62 South Korea drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 63 Australia drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 64 Australia drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 65 Australia drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 66 Latin America drug delivery devices market, by region, 2021 - 2033 (USD Billion)
Table 67 Latin America drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 68 Latin America drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 69 Latin America drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 70 Brazil drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 71 Brazil drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 72 Brazil drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 73 Argentina drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 74 Argentina drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 75 Argentina drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 76 Middle East and Africa drug delivery devices market, by region, 2021 - 2033 (USD Billion)
Table 77 Middle East and Africa drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 78 Middle East and Africa drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 79 Middle East and Africa drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 80 South Africa drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 81 South Africa drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 82 South Africa drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 83 Saudi Arabia drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 84 Saudi Arabia drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 85 Saudi Arabia drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 86 UAE drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 87 UAE drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 88 UAE drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
Table 89 Kuwait drug delivery devices market, by product, 2021 - 2033 (USD Billion)
Table 90 Kuwait drug delivery devices market, by application, 2021 - 2033 (USD Billion)
Table 91 Kuwait drug delivery devices market, by end-use, 2021 - 2033 (USD Billion)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Drug delivery devices market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Drug delivery devices market, Product outlook key takeaways (USD Million)
Fig. 12 Drug delivery devices market Product movement analysis 2025 & 2033 (USD Million)
Fig. 13 Inhalers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Injection devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 Prefilled syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 Auto-injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Pen injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Needle-free injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Wearable injectors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Contraceptive implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Drug-eluting stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Biodegradable implants market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Topical delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Creams market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Gels market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Ointments market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Oral delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Occular delivery system market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Nebulizers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Transdermal patches market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Infusion pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Drug delivery devices market, application outlook key takeaways (USD Million)
Fig. 39 Drug delivery devices market application movement analysis 2025 & 2033 (USD Million)
Fig. 40 Oncology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Infectious diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Respiratory diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Cardiovascular diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Autoimmune diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Central nervous system disorders market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Drug delivery devices market, end use outlook key takeaways (USD Million)
Fig. 49 Drug delivery devices market, end use movement analysis 2025 & 2033 (USD Million)
Fig. 50 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Diagnostic centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Million)
Fig. 53 Home care settings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Drug delivery devices market: Regional key takeaways (USD Million)
Fig. 56 Drug delivery devices market regional outlook, 2025 & 2033, USD Million
Fig. 57 North America drug delivery devices estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 US drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Canada drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 Mexico drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Europe drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 UK drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Germany drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 France drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 65 Spain drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 66 Italy drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 67 Sweden drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 68 Norway drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 Denmark drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Asia Pacific drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 China drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Japan drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 India drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 South Korea drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 Australia drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Thailand drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Latin America drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Brazil drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Argentina drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 South Africa drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 UAE drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 84 Kuwait drug delivery devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 List of key emerging company’s/distribution channel disruptors/innovators